The Situation Mid-Size Pharma, High-Potential HCP Identification A mid-sized pharmaceutical company partnered with Trinity AI to revamp its targeting strategy with the goal of reinvigorating one of their brands across multiple indications to drive new patient growth. They…
The Situation A mid-size biopharma company had an ambitious inorganic growth strategy but a fragmented data ecosystem, with each brand and function using its own data universe. There were a variety of data sources, models and integrations. Every…
Trinity AI’s GenAI-powered process automation solution to improve data operations efficiency won QC Data Management Solution of the Year in the 2024 BioTech Breakthrough Awards. Explore Trinity AI The Situation Pharmaceutical companies are mandated to…
Trinity was able to develop an advanced machine learning algorithm to predict potential site alerts for HCPs in the target universe
Trinity was able to deploy a solution in 3 weeks to increase market share of target prescribers through an AI-powered Next Best Action model
In order to plan and efficiently utilize their sales and marketing efforts, a mid-sized biopharma client wanted to identify HCPs likely to adopt their drug in the early stage of launch
A large biopharma customer wanted to develop a dynamic targeting solution for HCPs in a particular market
As part of an enterprise-wide Digital Transformation initiative, our client was looking to optimize effectiveness of marketing execution channels—and maximize clinical and commercial outcomes—by personalizing campaigns through engaging HCPs with the most relevant content (safety, efficacy, support, etc.)
A midsize biopharma client wanted to create a rep-centric tool to help them understand their targets and map against current performance and gaps, identify changes in market scenario, manage schedules, prioritize targets and deliver contextual content
A large biopharma customer wanted to optimize their digital channel strategy and outreach to most effectively engage with HCPs